Sutherland Everett Rand — SEC Form 4 filings
SEC reporting owner CIK 1852880. 8 Form 4 filings on record with FilingPulse; latest filed 2026-09-17.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-07-01 to 2026-09-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 3 legs across 3 filings — 6,283 shares, $43,725 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 7.
- Largest priced transaction: sale of 2,093 shares @ $9.29 ($19,444) in Upstream Bio, Inc., filed 2026-03-17.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Upstream Bio, Inc. (UPB) | Chief Executive Officer, Director | 5 | — | 3 legs · 6,283 sh · $43,725 | 3 |
| Krystal Biotech, Inc. (KRYS) | Director | 3 | — | — | 4 |
Form 4 filings — Sutherland Everett Rand
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-17 | 4 | Upstream Bio, Inc. (UPB) | Sale (S): 2,095 @ $5.49 | EDGAR |
| 2026-09-16 | 4 | Krystal Biotech, Inc. (KRYS) | Grant/award (A): 1,187 (derivative) @ $0 · Grant/award (A): 471 (derivative) @ $0 | EDGAR |
| 2026-06-17 | 4 | Upstream Bio, Inc. (UPB) | Sale (S): 2,095 @ $6.10 | EDGAR |
| 2026-03-17 | 4 | Upstream Bio, Inc. (UPB) | Sale (S): 2,093 @ $9.29 | EDGAR |
| 2026-01-06 | 4 | Upstream Bio, Inc. (UPB) | Grant/award (A): 75,000 @ $0 · Grant/award (A): 225,000 (derivative) @ $0 | EDGAR |
| 2025-06-30 | 4 | Krystal Biotech, Inc. (KRYS) | Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
| 2025-02-07 | 4 | Upstream Bio, Inc. (UPB) | Grant/award (A): 500,000 (derivative) @ $0 | EDGAR |
| 2024-07-01 | 4 | Krystal Biotech, Inc. (KRYS) | Grant/award (A): 5,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1852880 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →